Health Technologies

Medtech & IP Expertise group launches on LinkedIn

Leading international intellectual property firm Marks & Clerk has launched a new Medtech & IP Expertise group on the LinkedIn platform.

The group is a community of professionals who share a passion for medtech and its transformative potential across industries.

As a firm specialising in medical technology, Marks & Clerk is acutely aware of the unique challenges and opportunities that arise within this dynamic field, particularly regarding intellectual property rights, regulatory compliance, and ethical considerations.

Medical technology is continuously evolving, revolutionising healthcare delivery and profoundly impacting patient outcomes.

It is imperative to stay abreast of the latest innovations, potential avenues, and hurdles ahead.

The new community is dedicated to keeping you informed about the cutting-edge trends and advancements in medical technology whilst ensuring you are making the most of your IP protection.

Through the platform, you can engage in insightful discussions, connect with peers who share similar interests, exchange valuable insights and experiences, and establish connections with leading figures and experts in the field.

Whether you are a seasoned professional, an enthusiast, or simply intrigued by the latest developments in medical technology, the new group provides a tailored environment for fostering discussions, networking opportunities, and knowledge exchange focused on the intersection of technology and healthcare.

Find out more and join the group here

You may also like

Health Technologies

Accelerating Strategies Around Internet of Medical Things Devices

  • December 22, 2022
IoMT Device Integration with the Electronic Health Record Is Growing By their nature, IoMT devices are integrated into healthcare organizations’
Health Technologies

3 Health Tech Trends to Watch in 2023

Highmark Health also uses network access control technology to ensure computers are registered and allowed to join the network. The